Outlook Therapeutics OTLK
NASDAQ OTLK
$0.56 +0.04 (+7.94%)
At close: Oct 21, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) Work In Process (2025 - 2026)

Updated

Outlook Therapeutics' Work In Process came in at $2.51 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 32.9% from $3.75 million a year earlier but up 215.1% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Work In Process (2025 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Work In Process was $958,539.

  • The five-year range for quarterly Work In Process is $271,190 (fiscal Q2 2025) to $3.75 million (fiscal Q3 2025).
  • Business Quant data shows OTLK's Work In Process at $797,880 (Q2 2026), $1.11 million (Q1 2026) and $958,539 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Outlook Therapeutics 77.51 Mn 41.76 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.51 Mn
Mar 31, 2026 797,880.00
Dec 31, 2025 1.11 Mn
Sep 30, 2025 958,539.00
Jun 30, 2025 3.75 Mn
Mar 31, 2025 271,190.00
API Access

Outlook Therapeutics Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=OTLK&period=max&api_key=YOUR_API_KEY